Karen L Goldenthal
Biographic Data
| ID | 6061057 |
|---|---|
| NAME | Karen L Goldenthal |
| GIVEN NAMES | Karen L |
| FAMILY NAME | Goldenthal |
| SIGNATURE | GOLDENTHAL K L |
| AFFILIATIONS | At the time this article was written, Susan S. Ellenberg was with the Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, Md. Mary A. Foulkes, Karen Midthun, and Karen L. Goldenthal are with the Center for Biologics Evaluation and Research, US Food and Drug Administration. |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2005 |
| H-INDEX | 1 |
Evaluating the Safety of New Vaccines
Public concerns about the safety of vaccines arise on a regular basis. In November 2000, a workshop titled “Evaluation of New Vaccines: How Much Safety Data?” was convened by US Public Health Service agencies, including the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration, to discuss appropriate methods for evaluating the safety of…
Evaluating the Safety of New Vaccines
Public concerns about the safety of vaccines arise on a regular basis. In November 2000, a workshop titled “Evaluation of New Vaccines: How Much Safety Data?” was convened by US Public Health Service agencies, including the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration, to discuss appropriate methods for evaluating the safety of…
Evaluating the Safety of New Vaccines
Public concerns about the safety of vaccines arise on a regular basis. In November 2000, a workshop titled “Evaluation of New Vaccines: How Much Safety Data?” was convened by US Public Health Service agencies, including the Food and Drug Administration, the National Institutes of Health, the Centers for Disease Control and Prevention, and the Health Resources and Services Administration, to discuss appropriate methods for evaluating the safety of…
Administration (probate law) (1 works) · Advisory committee (1 works) · Disease control (1 works) · Environmental health (1 works) · Family medicine (1 works) · Food and drug administration (1 works) · Immunization (1 works) · Immunology (1 works) · Immunology (1 works) · Influenza Virus Research Studies (1 works)